Exact Mass: 364.10526500000003

Exact Mass Matches: 364.10526500000003

Found 82 metabolites which its exact mass value is equals to given mass value 364.10526500000003, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

10-HCPT

(19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H16N2O5 (364.1059166)

10-Hydroxycamptothecin is a pyranoindolizinoquinoline. 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)). 10-Hydroxycamptothecin is a natural product found in Nothapodytes nimmoniana, Camptotheca acuminata, and Fusarium solani with data available. D000970 - Antineoplastic Agents (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].

10-Hydroxycamptothecin

19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H16N2O5 (364.1059166)

(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

C15H17ClN6O3 (364.1050602)

11-Hydroxycamptothecin

11-Hydroxycamptothecin

C20H16N2O5 (364.1059166)

18-Hydroxycamptothecin

18-Hydroxycamptothecin

C20H16N2O5 (364.1059166)

CHEMBL432949

CHEMBL432949

C20H16N2O5 (364.1059166)

CHEMBL301951

CHEMBL301951

C20H16N2O5 (364.1059166)

Flavumindole

Flavumindole

C20H16N2O5 (364.1059166)

4-Ethyl-4,12-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione

4-Ethyl-4,12-dihydroxy-1H-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione

C20H16N2O5 (364.1059166)

Glu Cys Asn

Glu Cys Asn

C12H20N4O7S (364.10526500000003)

Gln Cys Asp

Gln Cys Asp

C12H20N4O7S (364.10526500000003)

Asp Gln Cys

Asp Gln Cys

C12H20N4O7S (364.10526500000003)

SCHEMBL12696385

SCHEMBL12696385

C12H20N4O7S (364.10526500000003)

Cys Gln Asp

Cys Gln Asp

C12H20N4O7S (364.10526500000003)

Hydroxy camptothecine

19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione

C20H16N2O5 (364.1059166)

D000970 - Antineoplastic Agents (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity. (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.

10-Hydroxycamptothecin

10-Hydroxy camptothecin

C20H16N2O5 (364.1059166)

SubCategory_DNP: : Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 0.944 D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.947 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.929 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.928 (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4]. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment[1][2][3][4].

10-HYDROXY-CAMPTOTHECIN

NCGC00095986-02!10-HYDROXY-CAMPTOTHECIN

C20H16N2O5 (364.1059166)

Ala Cys Asp Gly

(3S)-3-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Ala Cys Gly Asp

(2S)-2-{2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]acetamido}butanedioic acid

C12H20N4O7S (364.10526500000003)

Ala Asp Cys Gly

(3S)-3-[(2S)-2-aminopropanamido]-3-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Ala Asp Gly Cys

(3S)-3-[(2S)-2-aminopropanamido]-3-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Ala Gly Cys Asp

(2S)-2-[(2R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-sulfanylpropanamido]butanedioic acid

C12H20N4O7S (364.10526500000003)

Ala Gly Asp Cys

(3S)-3-{2-[(2S)-2-aminopropanamido]acetamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Cys Ala Asp Gly

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Cys Ala Gly Asp

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]acetamido}butanedioic acid

C12H20N4O7S (364.10526500000003)

Cys Asp Ala Gly

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Cys Asp Gly Ala

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Cys Glu Gly Gly

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)butanoic acid

C12H20N4O7S (364.10526500000003)

Cys Gly Ala Asp

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}propanamido]butanedioic acid

C12H20N4O7S (364.10526500000003)

Cys Gly Asp Ala

(3S)-3-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Cys Gly Glu Gly

(4S)-4-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C12H20N4O7S (364.10526500000003)

Cys Gly Gly Glu

(2S)-2-(2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}acetamido)pentanedioic acid

C12H20N4O7S (364.10526500000003)

Asp Ala Cys Gly

(3S)-3-amino-3-{[(1S)-1-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Asp Ala Gly Cys

(3S)-3-amino-3-{[(1S)-1-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Asp Cys Ala Gly

(3S)-3-amino-3-{[(1R)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Asp Cys Gly Ala

(3S)-3-amino-3-{[(1R)-1-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Asp Gly Ala Cys

(3S)-3-amino-3-[({[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Asp Gly Cys Ala

(3S)-3-amino-3-[({[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C12H20N4O7S (364.10526500000003)

Glu Cys Gly Gly

(4S)-4-amino-4-{[(1R)-1-({[(carboxymethyl)carbamoyl]methyl}carbamoyl)-2-sulfanylethyl]carbamoyl}butanoic acid

C12H20N4O7S (364.10526500000003)

Glu Gly Cys Gly

(4S)-4-amino-4-[({[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C12H20N4O7S (364.10526500000003)

Glu Gly Gly Cys

(4S)-4-amino-4-({[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]methyl}carbamoyl)butanoic acid

C12H20N4O7S (364.10526500000003)

Gly Ala Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-sulfanylpropanamido]butanedioic acid

C12H20N4O7S (364.10526500000003)

Gly Ala Asp Cys

(3S)-3-[(2S)-2-(2-aminoacetamido)propanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Gly Cys Ala Asp

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]propanamido]butanedioic acid

C12H20N4O7S (364.10526500000003)

Gly Cys Asp Ala

(3S)-3-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Gly Cys Glu Gly

(4S)-4-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-[(carboxymethyl)carbamoyl]butanoic acid

C12H20N4O7S (364.10526500000003)

Gly Cys Gly Glu

(2S)-2-{2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]acetamido}pentanedioic acid

C12H20N4O7S (364.10526500000003)

Gly Asp Ala Cys

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Gly Asp Cys Ala

(3S)-3-(2-aminoacetamido)-3-{[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C12H20N4O7S (364.10526500000003)

Gly Glu Cys Gly

(4S)-4-(2-aminoacetamido)-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid

C12H20N4O7S (364.10526500000003)

Gly Glu Gly Cys

(4S)-4-(2-aminoacetamido)-4-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]butanoic acid

C12H20N4O7S (364.10526500000003)

Gly Gly Cys Glu

(2S)-2-[(2R)-2-[2-(2-aminoacetamido)acetamido]-3-sulfanylpropanamido]pentanedioic acid

C12H20N4O7S (364.10526500000003)

Gly Gly Glu Cys

(4S)-4-[2-(2-aminoacetamido)acetamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C12H20N4O7S (364.10526500000003)

Asp Gln Cys

Asp Gln Cys

C12H20N4O7S1 (364.10526500000003)

Gln Cys Asp

Gln Cys Asp

C12H20N4O7S1 (364.10526500000003)

Cys Gln Asp

Cys Gln Asp

C12H20N4O7S1 (364.10526500000003)

Cys Glu Asn

Cys Glu Asn

C12H20N4O7S1 (364.10526500000003)

Asn Cys Glu

Asn Cys Glu

C12H20N4O7S1 (364.10526500000003)

Cys Asp Gln

Cys Asp Gln

C12H20N4O7S1 (364.10526500000003)

Glu Asn Cys

Glu Asn Cys

C12H20N4O7S1 (364.10526500000003)

Glu Cys Asn

Glu Cys Asn

C12H20N4O7S1 (364.10526500000003)

Asp Cys Gln

Asp Cys Gln

C12H20N4O7S1 (364.10526500000003)

Gln Asp Cys

Gln Asp Cys

C12H20N4O7S1 (364.10526500000003)

Cys Asn Glu

Cys Asn Glu

C12H20N4O7S1 (364.10526500000003)

Asn Glu Cys

Asn Glu Cys

C12H20N4O7S1 (364.10526500000003)

9-Hydroxycamptothecin

9-Hydroxycamptothecin

C20H16N2O5 (364.1059166)

ethyl 2-[3-(1H-benzimidazol-2-yl)-2-oxochromen-7-yl]oxyacetate

ethyl 2-[3-(1H-benzimidazol-2-yl)-2-oxochromen-7-yl]oxyacetate

C20H16N2O5 (364.1059166)

Camptothecin N-oxide

Camptothecin N-oxide

C20H16N2O5 (364.1059166)

(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

(E)-1-(4-((6-Amino-5-((methoxyimino)methyl)pyrimidin-4-yl)oxy)-2-chlorophenyl)-3-ethylurea

C15H17ClN6O3 (364.1050602)

5-Hydroxycamptothecin

5-Hydroxycamptothecin

C20H16N2O5 (364.1059166)

Glu-Cys-Asn

Glu-Cys-Asn

C12H20N4O7S (364.10526500000003)

Asp-Cys-Gln

Asp-Cys-Gln

C12H20N4O7S (364.10526500000003)

Asp-Gln-Cys

Asp-Gln-Cys

C12H20N4O7S (364.10526500000003)

Gln-Asp-Cys

Gln-Asp-Cys

C12H20N4O7S (364.10526500000003)

Asn-Cys-Glu

Asn-Cys-Glu

C12H20N4O7S (364.10526500000003)

Asn-Glu-Cys

Asn-Glu-Cys

C12H20N4O7S (364.10526500000003)

Cys-Asn-Glu

Cys-Asn-Glu

C12H20N4O7S (364.10526500000003)

Cys-Asp-Gln

Cys-Asp-Gln

C12H20N4O7S (364.10526500000003)

Cys-Gln-Asp

Cys-Gln-Asp

C12H20N4O7S (364.10526500000003)

Cys-Glu-Asn

Cys-Glu-Asn

C12H20N4O7S (364.10526500000003)

Gln-Cys-Asp

Gln-Cys-Asp

C12H20N4O7S (364.10526500000003)

Glu-Asn-Cys

Glu-Asn-Cys

C12H20N4O7S (364.10526500000003)